Advertisement

Advertisement

SXTP Stock Latest News

60 Degrees executes patent licensing agreement with Florida State

The Fly60 Degrees executes patent licensing agreement with Florida State

60 Degrees details tafenoquine priority review voucher strategy

PremiumCompany Announcements

60 Degrees details tafenoquine priority review voucher strategy

16d ago

60 Degrees announces early enrollment of first patient in trial of tafenoquine

PremiumThe Fly

60 Degrees announces early enrollment of first patient in trial of tafenoquine

24d ago

H.C. Wainwright downgrades 60 Degrees on ‘untenable’ spending

PremiumThe Fly

H.C. Wainwright downgrades 60 Degrees on ‘untenable’ spending

30d ago

60 Degrees Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright

PremiumThe Fly

60 Degrees Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright

30d ago

60 Degrees Pharmaceuticals reports Arakoda availability on Runway Health website

PremiumThe Fly60 Degrees Pharmaceuticals reports Arakoda availability on Runway Health website

2M ago

SXTP Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Pre-Earnings

SXTP Earnings Report this Week: Is It a Buy, Ahead of Earnings?

3M ago

60 Degrees Updates Affiliate Share Ownership Disclosure Error

Company Announcements

60 Degrees Updates Affiliate Share Ownership Disclosure Error

3M ago

60 Degrees submits NDIN to FDA for Australian Chestnut Extract

PremiumThe Fly

60 Degrees submits NDIN to FDA for Australian Chestnut Extract

3M ago

60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering

PremiumCompany Announcements

60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering

3M ago

60 Degrees Pharmaceuticals Updates Opinion for ATM Program

PremiumCompany Announcements

60 Degrees Pharmaceuticals Updates Opinion for ATM Program

3M ago

60 Degrees reports all patients cured of babesiosis after tafenoquine treatment

PremiumThe Fly

60 Degrees reports all patients cured of babesiosis after tafenoquine treatment

3M ago

60 Degrees Pharmaceuticals Regains Nasdaq Listing Compliance Status

PremiumCompany Announcements60 Degrees Pharmaceuticals Regains Nasdaq Listing Compliance Status

4M ago

60 Degrees expands access to Arakoda with GoodRx partnership

The Fly

60 Degrees expands access to Arakoda with GoodRx partnership

5M ago

60 Degrees Pharmaceuticals to exercise option in agreement with FSU

The Fly

60 Degrees Pharmaceuticals to exercise option in agreement with FSU

5M ago

Runway Health Partnership and Multi-Pronged Commercial Strategy Underpin Buy Rating on 60 Degrees Pharmaceuticals

PremiumRatings

Runway Health Partnership and Multi-Pronged Commercial Strategy Underpin Buy Rating on 60 Degrees Pharmaceuticals

5M ago

60 Degrees Pharmaceuticals target adjusted to $24 at H.C. Wainwright after split

PremiumThe Fly

60 Degrees Pharmaceuticals target adjusted to $24 at H.C. Wainwright after split

5M ago

60 Degrees Pharmaceuticals Faces Immediate Nasdaq Delisting Appeal

PremiumCompany Announcements

60 Degrees Pharmaceuticals Faces Immediate Nasdaq Delisting Appeal

5M ago

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!

PremiumMarket News

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!

5M ago

Here’s Why 60 Degrees Pharmaceuticals Stock (SXTP) Rocketed Today

PremiumMarket NewsHere’s Why 60 Degrees Pharmaceuticals Stock (SXTP) Rocketed Today

5M ago

60 Degrees Pharmaceuticals announces partnership with Runway Health

The Fly

60 Degrees Pharmaceuticals announces partnership with Runway Health

5M ago

60 Degrees Pharmaceuticals Implements One-for-Four Reverse Split

Company Announcements

60 Degrees Pharmaceuticals Implements One-for-Four Reverse Split

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >